$4.91 Billion in Sales Expected for Kimberly-Clark Co. (NYSE:KMB) This Quarter

Wall Street brokerages forecast that Kimberly-Clark Co. (NYSE:KMBGet Rating) will announce sales of $4.91 billion for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Kimberly-Clark’s earnings. The highest sales estimate is $4.98 billion and the lowest is $4.83 billion. Kimberly-Clark reported sales of $4.72 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 4%. The business is expected to issue its next quarterly earnings report before the market opens on Monday, January 1st.

On average, analysts expect that Kimberly-Clark will report full year sales of $20.15 billion for the current fiscal year, with estimates ranging from $20.11 billion to $20.23 billion. For the next year, analysts expect that the company will report sales of $20.64 billion, with estimates ranging from $20.50 billion to $20.71 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Kimberly-Clark.

Kimberly-Clark (NYSE:KMBGet Rating) last issued its quarterly earnings results on Friday, April 22nd. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.12. Kimberly-Clark had a return on equity of 253.93% and a net margin of 8.86%. The company had revenue of $5.10 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same period in the previous year, the firm posted $1.80 EPS. Kimberly-Clark’s revenue was up 7.4% on a year-over-year basis.

KMB has been the subject of several research reports. Sanford C. Bernstein cut shares of Kimberly-Clark from a “market perform” rating to an “underperform” rating and set a $126.00 price objective for the company. in a research note on Wednesday, February 2nd. The Goldman Sachs Group lowered their price objective on shares of Kimberly-Clark from $130.00 to $124.00 in a research note on Tuesday, March 29th. Royal Bank of Canada boosted their price objective on shares of Kimberly-Clark from $122.00 to $124.00 and gave the company a “sector perform” rating in a research note on Monday, April 25th. Citigroup upped their price target on shares of Kimberly-Clark from $113.00 to $119.00 and gave the stock a “sell” rating in a research report on Thursday, January 27th. Finally, Barclays decreased their price target on shares of Kimberly-Clark from $129.00 to $124.00 and set an “equal weight” rating for the company in a research report on Monday. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $132.38.

Shares of NYSE KMB opened at $131.37 on Thursday. Kimberly-Clark has a 52-week low of $117.32 and a 52-week high of $145.79. The firm has a fifty day moving average of $130.38 and a 200-day moving average of $133.47. The stock has a market capitalization of $44.26 billion, a PE ratio of 25.31, a P/E/G ratio of 4.43 and a beta of 0.37. The company has a quick ratio of 0.50, a current ratio of 0.81 and a debt-to-equity ratio of 9.49.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 5th. Shareholders of record on Friday, June 10th will be given a $1.16 dividend. The ex-dividend date of this dividend is Thursday, June 9th. This represents a $4.64 dividend on an annualized basis and a yield of 3.53%. Kimberly-Clark’s payout ratio is currently 89.40%.

In other news, insider Doug Cunningham sold 3,627 shares of the company’s stock in a transaction dated Monday, May 2nd. The shares were sold at an average price of $138.00, for a total value of $500,526.00. Following the sale, the insider now owns 4,242 shares in the company, valued at approximately $585,396. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Tristram Wilkinson sold 2,069 shares of the company’s stock in a transaction dated Thursday, May 5th. The shares were sold at an average price of $137.17, for a total transaction of $283,804.73. Following the completion of the sale, the insider now owns 14,102 shares in the company, valued at approximately $1,934,371.34. The disclosure for this sale can be found here. Over the last three months, insiders sold 62,696 shares of company stock valued at $8,807,911. 0.55% of the stock is currently owned by corporate insiders.

Several institutional investors have recently modified their holdings of KMB. Marshall Wace LLP acquired a new stake in Kimberly-Clark during the fourth quarter worth about $25,000. Bivin & Associates Inc. acquired a new stake in Kimberly-Clark during the fourth quarter worth about $26,000. HWG Holdings LP acquired a new stake in Kimberly-Clark during the fourth quarter worth about $29,000. Lumature Wealth Partners LLC raised its stake in Kimberly-Clark by 66.4% during the fourth quarter. Lumature Wealth Partners LLC now owns 208 shares of the company’s stock worth $30,000 after acquiring an additional 83 shares during the period. Finally, Roble Belko & Company Inc raised its stake in Kimberly-Clark by 69.5% during the first quarter. Roble Belko & Company Inc now owns 256 shares of the company’s stock worth $32,000 after acquiring an additional 105 shares during the period. Institutional investors and hedge funds own 74.32% of the company’s stock.

Kimberly-Clark Company Profile (Get Rating)

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names.

Recommended Stories

Get a free copy of the Zacks research report on Kimberly-Clark (KMB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Kimberly-Clark (NYSE:KMB)

Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.